Nevertheless, CLL-1 could not differentiate normal HSCs from cancerous stem cells since genetic mutations linked to MDS were also present in the CD34+/CD38−/CLL-1 − group [36]. The gene discussed is CD34; the disease is myelodysplastic syndrome.